• Français Français French fr
  • English English English en
Bidermato
  • Tables
  • Sheets & Prints
    • Psoriasis
      • Bimzelx
      • Cimzia
      • Cosentyx
      • Enbrel
      • Humira
      • Ilumya
      • Otezla
      • Remicade
      • Siliq
      • Skyrizi
      • Sotyktu
      • Stelara
      • Taltz
      • Tremfya
    • Generalized pustular psoriasis
      • Spevigo
    • Atopic dermatitis
      • Adtralza
      • Cibinqo
      • Dupixent
      • Ebglyss
      • Rinvoq
    • Prurigo nodularis
      • Dupixent
    • Urticaria
      • Xolair
    • Hidradenitis suppurativa
      • Humira
    • Alopecia areata
      • Litfulo
      • Olumiant
    • General RAMQ Forms
  • Reimbursement
    • Atopic dermatitis
      • Reimbursement criteria
    • Hidradenitis suppurativa
      • Reimbursement criteria
    • Psoriasis
      • Contraindications
      • Reimbursement criteria
    • Urticaria
      • Reimbursement criteria
  • Biosimilars
  • Generic drugs
  • Vaccination
  • COVID-19
    • CDA Biologiques vs COVID19
    • Lettre employeur COVID19 Pas immunosupp
    • Lettre employeur COVID19 Dupixent
    • Vaccines (for patients)
    • Vaccines (for physicians)
  • Tools
    • Atopic dermatitis
      • EASI
        • EASI Training Video
        • EASI: Quick Reference Sheet
        • EASI Investigator Training Document
        • EASI Calculator
      • Patient teaching tool
      • AD assessment report
      • Sheets for physicians (JAKi)
        • Cibinqo
        • Rinvoq
    • Psoriasis
      • PASI Calculator
      • DLQI Questionnaire
      • Patient teaching tool
      • Brochure from Dr Yves Poulin
      • Travel (patient pamphlet)
    • Alopecia areata
      • SALT
    • Topical anti-inflammatory treatments
      • Poster
      • Table (short version, french only)
      • Table (extended version, french only)
    • Urticaria
      • UAS7 Questionnaire
    • Lab
      • Lab follow-up (anti-JAK)
  • Search
  • Menu Menu

SILIQ-Brodalumab_PATIENT_Enrol_FRANCAIS

18 April 2024/by metamorfic

Share this entry
  • Share on Facebook
  • Share on X
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
http://www.bidermato.com/wp-content/uploads/2017/05/bidermato-en.png 0 0 metamorfic http://www.bidermato.com/wp-content/uploads/2017/05/bidermato-en.png metamorfic2024-04-18 13:57:022024-04-18 13:57:02SILIQ-Brodalumab_PATIENT_Enrol_FRANCAIS

About & Terms of use
Privacy Policy
Contact : info@bidermato.com

Idea and contents :
Dr. Hélène Veillette, MD, FRCPC
(Dermatologist, Associate Clinical Professor)

© Copyright - BIDermato - 2016
Web design Metamorfic.ca

Scroll to top